Literature DB >> 30035700

Depression severity is associated with increased inflammation in veterans with peripheral artery disease.

Natalie Vm Hernandez1, Joel L Ramirez1, Sukaynah A Khetani1,2, Kimberly A Spaulding1,2, Warren J Gasper1,2, Jade Hiramoto1, Daniel Lindqvist3,4, Owen M Wolkowitz3, Nancy K Hills5, S Marlene Grenon1,2, Greg J Zahner1.   

Abstract

The present study examines the association between depressive symptoms and inflammatory markers in peripheral artery disease (PAD) to better understand the mechanistic relationship between depression and PAD. A cross-sectional sample of 117 patients with PAD (97% male, 76% Caucasian) was recruited from the San Francisco Veterans Affairs Medical Center. Patients were categorized into three subgroups based upon current depressive symptom severity, as defined by Patient Health Questionnaire-8 scores: no symptoms (score of 0-4, n = 62), mild symptoms (score of 5-9, n = 33), and moderate/severe symptoms (score ≥ 10, n = 22). Serum levels of high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), soluble intercellular adhesion molecule-1 (ICAM-1), and tumor necrosis factor-alpha (TNF-α) were assayed and log-transformed for multivariable analysis. To decrease the possibility of Type 1 errors, inflammatory markers were standardized and summed to create a total inflammatory score. In a multivariable analysis controlling for demographics, PAD severity, and atherosclerotic risk factors, mild and moderate/severe depressive symptoms were predictive of a higher total inflammatory score when compared to the group with no symptoms (mild symptoms p = 0.04, moderate/severe symptoms p = 0.007). Exploratory multivariable analyses of individual inflammatory markers found IL-6 levels were significantly higher in the moderate/severe symptoms group ( p = 0.006) than in the no symptoms group. Moreover, hs-CRP and ICAM-1 trended upwards with increasing depression severity. TNF-α was not associated with depression severity. We conclude that depressive symptom severity was independently associated with greater inflammation in PAD. Future research should examine the strength and directionality of this association through larger prospective cohort studies, as well as investigate the pathophysiological mechanisms responsible.

Entities:  

Keywords:  depression; inflammation; peripheral artery disease (PAD)

Mesh:

Substances:

Year:  2018        PMID: 30035700     DOI: 10.1177/1358863X18787640

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  4 in total

1.  A prospective investigation of depression and adverse outcomes in patients undergoing vascular surgical interventions: A retrospective cohort study using a large mental health database in South London.

Authors:  Sajini Kuruppu; Marvey Ghani; Megan Pritchard; Matthew Harris; Ruwan Weerakkody; Robert Stewart; Gayan Perera
Journal:  Eur Psychiatry       Date:  2021-01-18       Impact factor: 5.361

2.  The association between C-reactive protein, mood disorder, and cognitive function in UK Biobank.

Authors:  David C Milton; Joey Ward; Emilia Ward; Donald M Lyall; Rona J Strawbridge; Daniel J Smith; Breda Cullen
Journal:  Eur Psychiatry       Date:  2021-02-01       Impact factor: 5.361

Review 3.  Inflammatory Depression-Mechanisms and Non-Pharmacological Interventions.

Authors:  Klara Suneson; Jesper Lindahl; Simon Chamli Hårsmar; Gustav Söderberg; Daniel Lindqvist
Journal:  Int J Mol Sci       Date:  2021-02-06       Impact factor: 5.923

4.  Fat compartments in patients with depression: A meta-analysis.

Authors:  Alisa S Cosan; Julietta U Schweiger; Kai G Kahl; Bettina Hamann; Michael Deuschle; Ulrich Schweiger; Anna L Westermair
Journal:  Brain Behav       Date:  2020-11-05       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.